首頁 > 市場調查報告書 > 製藥

生物製劑分子標靶治療學

市場調查報告書

商品編碼

1468150

2024-2032 年單株抗體市場報告（依生產方法、來源、適應症、最終用途和地區）

Monoclonal Antibodies Market Report by Production Method, Source, Indication, End Use, and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年，全球IMARC Group抗體市場規模達到2,217億美元。

單株抗體 (mAb) 是實驗室生產的蛋白質，用作替代抗體，可增強、修改、恢復和模擬免疫系統對不必要的細胞的攻擊。它們用於透過增強免疫系統來檢測和靶向癌細胞以進行破壞。它們也用於阻斷癌細胞與促進細胞生長的蛋白質之間的關聯。此外，它們還可以阻止蛋白質的形成，使免疫系統細胞能夠有效地對抗癌細胞。除此之外，單株抗體將放射治療直接輸送到癌細胞，並最大限度地減少放射對健康細胞的影響

單株抗體市場趨勢：

目前，癌症、心臟病、中風、糖尿病和關節炎等慢性病的盛行率不斷上升，是推動市場的關鍵因素之一。除此之外，領先的製造商也廣泛投資於研發(R&D) 活動，推出用於治療神經退化性疾病（如阿茲海默症、亨廷頓氏症、帕金森氏症和路易氏體病）的增強型單克隆抗體藥物。他們也專注於各種行銷策略來擴大客戶群，這有助於市場的成長。此外，對治療癌細胞、免疫抑制和免疫調節分子等各種抗原的人源化單株抗體的需求不斷成長，為行業投資者提供了利潤豐厚的成長機會。除此之外，全球對用於治療癌症的具有成本效益的生物相似藥的需求不斷增加。這與蓬勃發展的醫療保健行業一起推動了市場的成長。此外，下一代定序等各種基因平台的技術進步正在提供積極的市場前景。此外，世界各地單株抗體生產中先進基因工程技術的應用增加。再加上大眾對單株抗體療法益處的認知不斷提高，正在推動市場成長。

本報告回答的關鍵問題

2023年全球單株抗體市場規模有多大？
2024-2032年全球單株抗體市場的預期成長率是多少？
推動全球單株抗體市場的關鍵因素是什麼？
COVID-19對全球單株抗體市場有何影響？
根據生產方法，全球單株抗體市場的詳細情形如何？
全球單株抗體市場依來源分類是怎樣的？
根據適應症，全球單株抗體市場的詳細情形如何？
根據最終用途，全球單株抗體市場的詳細情形如何？
全球單株抗體市場的重點區域有哪些？
全球單株抗體市場的主要參與者/公司有哪些？

Monoclonal antibodies (mAbs) are laboratory-produced proteins used to serve as substitute antibodies that can enhance, modify, restore, and mimic the attack of the immune system on unwanted cells. They are utilized for detecting and targetting cancer cells for destruction by enhancing the immune system. They are also employed to block the connection between a cancer cell and proteins that promote cell growth. In addition, they prevent the formation of proteins for enabling immune system cells to work efficiently against cancer cells. Besides this, mAbs transport the radiation treatment directly to cancer cells and minimize the effect of radiation on healthy cells

Monoclonal Antibodies Market Trends:

At present, the growing prevalence of chronic diseases, such as cancer, heart disease, stroke, diabetes, and arthritis, represents one of the key factors driving the market. Besides this, leading manufacturers are extensively investing in research and development (R&D) activities to introduce enhanced mAb drugs for treating neurodegenerative diseases, such as Alzheimer's, Huntington's, Parkinson's, and Lewy body diseases. They are also focusing on various marketing strategies to expand their customer base, which is contributing to the growth of the market. In addition, the increasing demand for humanized mAbs to treat various antigens, such as cancer cells, immunosuppression, and immunomodulatory molecules, are offering lucrative growth opportunities to industry investors. Apart from this, there is a rise in the demand for cost-efficient biosimilar mAbs to treat cancer across the globe. This, along with the burgeoning healthcare industry, is propelling the growth of the market. Moreover, technological advancements in various genetic platforms, such as next-generation sequencing, is offering a positive market outlook. Additionally, there is an increase in the employment of advanced genetic engineering technology in mAbs production around the world. This, coupled with the rising awareness among the masses about the benefits of mAb therapy, is bolstering the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global monoclonal antibodies market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on production method, source, indication and end use.

Breakup by Production Method:

In Vivo

In Vitro

Breakup by Source:

Murine

Chimeric

Humanized

Human

Breakup by Indication:

Cancer

Autoimmune Diseases

Inflammatory Diseases

Infectious Diseases

Others

Breakup by End Use:

Hospitals

Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Biogen Inc., F. Hoffmann-La Roche AG, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1. What was the size of the global monoclonal antibodies market in 2023?
2. What is the expected growth rate of the global monoclonal antibodies market during 2024-2032?
3. What are the key factors driving the global monoclonal antibodies market?
4. What has been the impact of COVID-19 on the global monoclonal antibodies market?
5. What is the breakup of the global monoclonal antibodies market based on the production method?
6. What is the breakup of the global monoclonal antibodies market based on the source?
7. What is the breakup of the global monoclonal antibodies market based on the indication?
8. What is the breakup of the global monoclonal antibodies market based on the end use?
9. What are the key regions in the global monoclonal antibodies market?
10. Who are the key players/companies in the global monoclonal antibodies market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Monoclonal Antibodies Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Production Method

6.1 In Vivo
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 In Vitro
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Source

7.1 Murine
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Chimeric
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Humanized
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Human
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Indication

8.1 Cancer
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Autoimmune Diseases
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Inflammatory Diseases
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Infectious Diseases
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by End Use

9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 AbbVie Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Amgen Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Biogen Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 F. Hoffmann-La Roche AG
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
- 15.3.5 GSK plc
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Johnson & Johnson
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Merck KGaA
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Novartis AG
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Novo Nordisk A/S
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Pfizer Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Sanofi S.A.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis
- 15.3.12 Thermo Fisher Scientific Inc.
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Monoclonal Antibodies Market: Major Drivers and Challenges
Figure 2: Global: Monoclonal Antibodies Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Monoclonal Antibodies Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Monoclonal Antibodies Market: Breakup by Production Method (in %), 2023
Figure 5: Global: Monoclonal Antibodies Market: Breakup by Source (in %), 2023
Figure 6: Global: Monoclonal Antibodies Market: Breakup by Indication (in %), 2023
Figure 7: Global: Monoclonal Antibodies Market: Breakup by End Use (in %), 2023
Figure 8: Global: Monoclonal Antibodies Market: Breakup by Region (in %), 2023
Figure 9: Global: Monoclonal Antibodies (In Vivo) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Monoclonal Antibodies (In Vivo) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Monoclonal Antibodies (In Vitro) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Monoclonal Antibodies (In Vitro) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Monoclonal Antibodies (Murine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Monoclonal Antibodies (Murine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Monoclonal Antibodies (Chimeric) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Monoclonal Antibodies (Chimeric) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Monoclonal Antibodies (Humanized) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Monoclonal Antibodies (Humanized) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Monoclonal Antibodies (Human) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Monoclonal Antibodies (Human) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Monoclonal Antibodies (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Monoclonal Antibodies (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Monoclonal Antibodies (Autoimmune Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Monoclonal Antibodies (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Monoclonal Antibodies (Inflammatory Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Monoclonal Antibodies (Inflammatory Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Monoclonal Antibodies (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Monoclonal Antibodies (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Monoclonal Antibodies (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Monoclonal Antibodies (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Monoclonal Antibodies (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Monoclonal Antibodies (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Monoclonal Antibodies (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Monoclonal Antibodies (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Monoclonal Antibodies (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Monoclonal Antibodies (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North America: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North America: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: United States: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: United States: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Canada: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Canada: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Asia-Pacific: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Asia-Pacific: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: China: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: China: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Japan: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Japan: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: India: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: India: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: South Korea: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: South Korea: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Australia: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Australia: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Indonesia: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Indonesia: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Others: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Europe: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Europe: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Germany: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Germany: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: France: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: France: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: United Kingdom: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: United Kingdom: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Italy: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Italy: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Spain: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Spain: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Russia: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Russia: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Latin America: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Latin America: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Brazil: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Brazil: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Mexico: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Mexico: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Middle East and Africa: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Middle East and Africa: Monoclonal Antibodies Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Global: Monoclonal Antibodies Industry: SWOT Analysis
Figure 87: Global: Monoclonal Antibodies Industry: Value Chain Analysis
Figure 88: Global: Monoclonal Antibodies Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Monoclonal Antibodies Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Monoclonal Antibodies Market Forecast: Breakup by Production Method (in Million US$), 2024-2032
Table 3: Global: Monoclonal Antibodies Market Forecast: Breakup by Source (in Million US$), 2024-2032
Table 4: Global: Monoclonal Antibodies Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 5: Global: Monoclonal Antibodies Market Forecast: Breakup by End Use (in Million US$), 2024-2032
Table 6: Global: Monoclonal Antibodies Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Monoclonal Antibodies Market: Competitive Structure
Table 8: Global: Monoclonal Antibodies Market: Key Players

02-2729-4219

+886-2-2729-4219